Portfolio company
Generare
France · £17.0m raised
Raised
£17.0m
Latest stage
Series A
Rounds recorded
1
Backed by
5 investors
Sectors
About
This company develops a discovery platform that generates molecular data from microbial genomes for pharmaceutical and crop protection companies to advance drug and product development.
SourceFunding history · 1
Similar companies
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
Genorare
This company develops an encrypted artificial intelligence platform for hospitals and pharmaceutical firms to diagnose rare diseases using genomic and electronic health record data.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Genomenon
This company develops genomic search engines and data platforms for pharmaceutical companies and clinical laboratories to assist in disease diagnosis and drug development.
Terray
This company develops a generative artificial intelligence and high-throughput experimentation platform for pharmaceutical and biotechnology organisations to accelerate small molecule drug discovery.
Evolutionary Genomics
This company provides a genomics research platform that identifies and validates genes for commercially valuable agricultural traits to serve seed companies and crop producers.
GenMD
The company develops an anonymised synthetic health data platform for pharmaceutical companies, academic researchers and healthcare systems to share medical records securely.
QuirieGen
This company develops single-cell multi-omic technologies and AI models for drug discovery and development within the pharmaceutical sector.
